SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-037561
Filing Date
2023-10-18
Accepted
2023-10-18 07:30:22
Documents
15
Period of Report
2023-10-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49771
2 ex16-1.htm EX-16.1 5402
3 ex16-1_001.jpg GRAPHIC 40694
4 ex16-1_002.jpg GRAPHIC 8467
  Complete submission text file 0001493152-23-037561.txt   299032

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20231016.xsd EX-101.SCH 3045
6 XBRL LABEL FILE abeo-20231016_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE abeo-20231016_pre.xml EX-101.PRE 22379
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3311
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 231330921
SIC: 2834 Pharmaceutical Preparations